Welcome to Transplant Creations.
We introduce reduced intensity conditioning autologous
and allogeneic (donor) bone marrow or peripheral blood
progenitor cell transplants as part of
initial therapy to improve disease outcome
and health care economics.
We worked on development of a method for administration of biopharmaceutical products and reduced
intensity conditioning autologous and allogeneic bone marrow or
peripheral blood progenitor cell transplants as core components,
with the goal to support
patient friendly and effective therapy.
The service department offers
services (Van Hoef Consulting) to the
biopharmaceutical, biotech and device industry in product
development in the therapeutic areas oncology
and hematology and
in hematopoietic cell transplantation and to the health care
For news visit the target sector
Glossary of Words.